# Pages: 28; Format: PDF (Downloadable)

    Key Highlights

  • The progress report of industrial cancer R&D in between 2011-18.

  • A report on the futuristic transformations in industrial cancer research.

  • All the major events which had some impact on the industry/community are included.

  • A detailed description of immuno-oncology (especially checkpoint inhibitors) drugs are included.

  • Financial milestones and the promising companies/startups are mentioned.

  • Significant FDA-approved therapies (both new drugs and label expansions) are segregated by their major mechanism of action.

  • Finally, five newer tools/technologies are included with their industrial progress in detail.

  • An update of the article will be provided by the end of this year.